{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T18:44:48Z","timestamp":1794077088429,"version":"4.8.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Bone and Joint Infection Society"},{"DOI":"10.13039\/501100012091","name":"NIHR Clinical Research Network Thames Valley and South Midlands","doi-asserted-by":"publisher","award":["Clinical Trials Fellowship"],"award-info":[{"award-number":["Clinical Trials Fellowship"]}],"id":[{"id":"10.13039\/501100012091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Orthopaedic infections, such as osteomyelitis, diabetic foot infection and prosthetic joint infection, are most commonly treated by a combination of surgical debridement and a prolonged course of systemic antibiotics, usually for at least 4\u20136\u2009weeks. Use of local antibiotics, implanted directly into the site of infection at the time of surgery, may improve antibiotic delivery and allow us to shorten the duration of systemic antibiotic therapy, thereby limiting the frequency of side effects, cost and selection pressure for antimicrobial resistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>SOLARIO is a multicentre open-label randomised controlled non-inferiority trial comparing short and long systemic antibiotic therapy alongside local antibiotic therapy. Adult patients with orthopaedic infection, who have given informed consent, will be eligible to participate in the study provided that no micro-organisms identified from deep tissue samples are resistant to locally implanted antibiotics. Participants will be randomised in a 1:1 ratio to receive either a short course (\u2264 7\u2009days) or currently recommended long course (\u2265 4\u2009weeks) of systemic antibiotics. The primary outcome will be treatment failure by 12\u2009months after surgery, as ascertained by an independent Endpoint Committee blinded to treatment allocation. An absolute non-inferiority margin of 10% will be used for both per-protocol and intention-to-treat populations. Secondary outcomes will include probable and definite treatment failure, serious adverse events, treatment side effects, quality of life scores and cost analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This study aims to assess a treatment strategy that may enable the reduction of systemic antibiotic use for patients with orthopaedic infection. If this strategy is non-inferior, this will be to the advantage of patients and contribute to antimicrobial stewardship.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      Clinicaltrials.gov,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03806166\">NCT03806166<\/jats:ext-link>\n                      . Registered on 11 November 2019.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-019-3832-3","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T10:03:13Z","timestamp":1575885793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Short or Long Antibiotic Regimes in Orthopaedics (SOLARIO): a randomised controlled open-label non-inferiority trial of duration of systemic antibiotics in adults with orthopaedic infection treated operatively with local antibiotic therapy"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3139-7237","authenticated-orcid":false,"given":"Maria","family":"Dudareva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"K\u00fcmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Vach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Kaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"McNally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Scarborough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,9]]},"reference":[{"key":"3832_CR1","unstructured":"Office for National Statistics. Prescription cost analysis, England 2016. 30 March 2017. https:\/\/digital.nhs.uk\/catalogue\/PUB23631. Accessed 30 Nov 2017."},{"key":"3832_CR2","first-page":"CD004439","volume":"9","author":"LO Conterno","year":"2013","unstructured":"Conterno LO, Turchi MD. Systemic antibiotics for treating chronic osteomyelitis in adults. Cochrane Database Syst Rev. 2013;9:CD004439.","journal-title":"Cochrane Database Syst Rev"},{"key":"3832_CR3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1056\/NEJMoa1710926","volume":"380","author":"HK Li","year":"2019","unstructured":"Li HK, Rombach I, Zambellas R, Walker AS, McNally MA, Atkins BL, et al. Oral versus intravenous antibiotics for bone and joint infection. N Engl J Med. 2019;380:425\u201336.","journal-title":"N Engl J Med"},{"key":"3832_CR4","unstructured":"Public Health England. English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Report 2018. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/759975\/ESPAUR_2018_report.pdf"},{"issue":"2","key":"3832_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.medmal.2017.01.007","volume":"47","author":"C Wintenberger","year":"2017","unstructured":"Wintenberger C, Guery B, Bonnet E, Castan B, Cohen R, Diamantis S, et al. Proposal for shorter antibiotic therapies. Med Mal Infect. 2017;47(2):92\u2013141.","journal-title":"Med Mal Infect"},{"key":"3832_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jhin.2004.03.022","volume":"57","author":"C Defez","year":"2004","unstructured":"Defez C, Fabbro-Peray P, Bouziges N, Gouby A, Mahamat A, Daures JP, Sotto A. Risk factors for multidrug-resistant Pseudomonas nosocomial infection. J Hosp Infect. 2004;57:209\u201316.","journal-title":"J Hosp Infect"},{"issue":"5","key":"3832_CR7","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/cid\/cis942","volume":"56","author":"Y Doi","year":"2013","unstructured":"Doi Y, Park YS, Rivera JI, Adams-Haduch JM, Hingwe A, Sordillo EM, et al. Community-associated extended-spectrum beta-lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis. 2013;56(5):641\u20138.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"3832_CR8","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1128\/AAC.05947-11","volume":"56","author":"R Ben-Ami","year":"2012","unstructured":"Ben-Ami R, Olshtain-Pops K, Krieger M, Oren I, Bishara J, Dan M, et al. Antibiotic exposure a risk factor for fluconazole-resistant Candida bloodstream infection. Antimicrob Agents Chemother. 2012;56(5):2518.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9431","key":"3832_CR9","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0140-6736(04)16727-5","volume":"364","author":"DP Lew","year":"2004","unstructured":"Lew DP, Waldvogel FA. Osteomyelitis. Lancet. 2004;364(9431):369\u20137.","journal-title":"Lancet."},{"issue":"1","key":"3832_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cid\/cis966","volume":"56","author":"DR Osmon","year":"2013","unstructured":"Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56(1):1\u201310.","journal-title":"Clin Infect Dis"},{"key":"3832_CR11","volume-title":"Proceedings of the International Consensus Meeting on Periprosthetic Joint Infection","author":"J Parvizi","year":"2013","unstructured":"Parvizi J, Gehrke T. Proceedings of the International Consensus Meeting on Periprosthetic Joint Infection. 2013. http:\/\/www.msis-na.org\/wp-content\/themes\/msis-temp\/pdf\/ism-periprosthetic-joint-information.pdf"},{"issue":"3","key":"3832_CR12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S1473-3099(01)00094-9","volume":"1","author":"D Stengel","year":"2001","unstructured":"Stengel D, Bauwens K, Sehouli J, Ekkernkamp A, Porzsolt F. Systematic review and meta-analysis of antibiotic therapy for bone and joint infections. Lancet Infect Dis. 2001;1(3):175\u201388.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"3832_CR13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/cid\/cir842","volume":"54","author":"B Spellberg","year":"2012","unstructured":"Spellberg B, Lipsky BA. Systemic antibiotic therapy for chronic osteomyelitis in adults. Clin Infect Dis. 2012;54(3):393\u2013407.","journal-title":"Clin Infect Dis"},{"key":"3832_CR14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00003086-198606000-00015","volume":"207","author":"ER Salvati","year":"1986","unstructured":"Salvati ER, Callagan JJ, Brause BD, Klein RF, Small RD. Reimplantation in infection. Elution of gentamicin from cement and beads. Clin Orthop Relat Res. 1986;207:83.","journal-title":"Clin Orthop Relat Res"},{"key":"3832_CR15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00003086-199310000-00011","volume":"295","author":"KW Klemm","year":"1993","unstructured":"Klemm KW. Antibiotic bead chains. Clin Orthop Relat Res. 1993;295:63\u201376.","journal-title":"Clin Orthop Relat Res"},{"key":"3832_CR16","first-page":"47","volume":"295","author":"SL Henry","year":"1993","unstructured":"Henry SL, Hood GA, Seligson D. Long-term implantation of gentamicin-polymethylmethacrylate antibiotic beads. Clin Orthop Relat Res. 1993;295:47\u201353.","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"3832_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/00016470152846547","volume":"72","author":"AG Della Valle","year":"2001","unstructured":"Della Valle AG, Bostrom M, Brause B, Harney C, Salvati EA. Effective bactericidal activity of tobramycin and vancomycin eluted from acrylic bone cement. Acta Orthop Scand. 2001;72(3):237\u201340.","journal-title":"Acta Orthop Scand"},{"key":"3832_CR18","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1302\/0301-620X.98B9.38057","volume":"98-B","author":"MA McNally","year":"2016","unstructured":"McNally MA, Ferguson JY, Lau ACK, Diefenbeck M, Scarborough M, Ramsden AJ, et al. Single-stage treatment of chronic osteomyelitis with a new absorbable, gentamicin-loaded, calcium sulphate\/hydroxyapatite biocomposite. A prospective series of 100 cases. Bone Joint J. 2016;98-B:1289\u201396.","journal-title":"Bone Joint J"},{"issue":"6","key":"3832_CR19","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1302\/0301-620X.96B6.32756","volume":"96-B","author":"JY Ferguson","year":"2014","unstructured":"Ferguson JY, Dudareva M, Riley ND, Stubbs D, Atkins BL, McNally MA. The use of a biodegradeable antibiotic-loaded calcium sulphate carrier containing tobramycin for the treatment of chronic osteomyelitis: a series of 195 cases. Bone Joint J. 2014;96-B(6):829\u201336.","journal-title":"Bone Joint J."},{"key":"3832_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.7150\/jbji.17234","volume":"2","author":"JY Ferguson","year":"2017","unstructured":"Ferguson JY, Diefenbeck M, McNally MA. Ceramic biocomposites as biodegradable antibiotic carriers in the treatment of bone infections. J Bone Joint Infect. 2017;2:38.","journal-title":"J Bone Joint Infect"},{"key":"3832_CR21","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ijantimicag.2011.03.008","volume":"38","author":"RE Barth","year":"2011","unstructured":"Barth RE, Vogely HC, Hoepelman AIM, Peters EJG. To bead or not to bead? Treatment of osteomyelitis and prosthetic joint-associated infections with gentamicin bead chains. Int J Antimicrob Agents. 2011;38:371\u20135.","journal-title":"Int J Antimicrob Agents"},{"key":"3832_CR22","first-page":"171","volume":"205","author":"GHIM Walenkamp","year":"1986","unstructured":"Walenkamp GHIM, Vree TB, van Rens TJG. Gentamicin-PMMA beads. Pharmacokinetic and nephrotoxicological study. Clin Orthop Relat Res. 1986;205:171.","journal-title":"Clin Orthop Relat Res"},{"key":"3832_CR23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00003086-199310000-00008","volume":"295","author":"RC Haydon","year":"1993","unstructured":"Haydon RC, Blaha JD, Mancinelli C, Koike K. Audiometric thresholds in osteomyelitis patients treated with gentamicin-impregnated methylmethacrylate beads (Septopal). Clin Orthop Relat Res. 1993;295:43\u20136.","journal-title":"Clin Orthop Relat Res"},{"issue":"7","key":"3832_CR24","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1128\/AAC.00080-16","volume":"60","author":"D Pfoerringer","year":"2016","unstructured":"Pfoerringer D, Obermeier A, Kiokekli M, Buechner H, Vogt S, Stemberger A, et al. Antimicrobial formulations of absorbable bone substitute materials as drug carriers based on calcium sulfate. Antimicrob Agents Chemother. 2016;60(7):3897.","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"3832_CR25","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1302\/0301-620X.99B11.BJJ-2016-0298.R3","volume":"99-B","author":"P Wahl","year":"2017","unstructured":"Wahl P, Guidi M, Benninger E, Roenn K, Gautier E, Buclin T, et al. The levels of vancomycin in the blood and the wound after the local treatment of bone and soft-tissue infection with antibiotic-loaded calcium sulphate as carrier material. Bone Joint J. 2017;99-B(11):1537\u201344.","journal-title":"Bone Joint J."},{"key":"3832_CR26","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1302\/0301-620X.90B2.19855","volume":"90-B","author":"I Stockley","year":"2008","unstructured":"Stockley I, Mockford BJ, Hoad-Reddick A, Norman P. The use of two-stage exchange arthroplasty with depot antibiotics in the absense of long-term antibiotic therapy in infected total hip replacement. J Bone Joint Surg Br. 2008;90-B:145\u20138.","journal-title":"J Bone Joint Surg Br"},{"key":"3832_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/AAC.03676-14","volume":"59","author":"RP Howlin","year":"2015","unstructured":"Howlin RP, Brayford MJ, Webb JS, Cooper JJ, Aiken SS, Stoodley P. Antibiotic-loaded synthetic calcium sulfate beads for prevention of bacterial colonization and biofilm formation in periprosthetic infections. Antimicrob Agents Chemother. 2015;59:111.","journal-title":"Antimicrob Agents Chemother"},{"key":"3832_CR28","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1302\/2046-3758.59.BJR-2016-0108.R1","volume":"5","author":"M Stravinskas","year":"2016","unstructured":"Stravinskas M, Horstmann P, Ferguson J, Hettwer W, Nilsson M, Tarasevicius S, et al. Pharmacokinetics of gentamicin eluted from a regenerating bone graft substitute. In vitro and clinical release studies. Bone Joint Res. 2016;5:427\u201335.","journal-title":"Bone Joint Res"},{"issue":"8","key":"3832_CR29","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.arth.2007.08.020","volume":"23","author":"DJ Van Moojen","year":"2008","unstructured":"Van Moojen DJ, Hentenaar B, Vogely CH, Verbout AJ, Castelein RM, Dhert WJ. In vitro release of antibiotics from commercial PMMA beads and articulating hip spacers. J Arthroplast. 2008;23(8):1152.","journal-title":"J Arthroplast"},{"issue":"3","key":"3832_CR30","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1302\/0301-620X.63B3.7021561","volume":"63-B","author":"HW Buchholz","year":"1981","unstructured":"Buchholz HW, Elson RA, Engelbrecht E, Lodenkaemper H, Roettger J, Siegel A. Management of deep infection of total hip replacement. J Bone Joint Surg Br. 1981;63-B(3):342.","journal-title":"J Bone Joint Surg Br"},{"key":"3832_CR31","first-page":"23","volume":"295","author":"JH Calhoun","year":"1993","unstructured":"Calhoun JH, Henry SL, Anger DM, Cobos JA, Mader JT. The treatment of infected nonunions with gentamicin-polymethylmethacrylate antibiotic beads. Clin Orthop Relat Res. 1993;295:23\u20137.","journal-title":"Clin Orthop Relat Res"},{"key":"3832_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1046\/j.1469-0691.2001.00186.x","volume":"7","author":"K Klemm","year":"2001","unstructured":"Klemm K. The use of antibiotic-containing bead chains in the treatment of chronic bone infections. Clin Microbiol Infect. 2001;7:23\u201331.","journal-title":"Clin Microbiol Infect"},{"key":"3832_CR33","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1302\/0301-620X.84B1.0840070","volume":"84-B","author":"T Taggart","year":"2002","unstructured":"Taggart T, Kerry RM, Norman P, Stockley I. The use of vancomycin-impregnated cement beads in the management of infection of prosthetic joints. J Bone Joint Surg Br. 2002;84-B:70\u20132.","journal-title":"J Bone Joint Surg Br"},{"key":"3832_CR34","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1302\/0301-620X.87B2.15640","volume":"87-B","author":"DA Hoad-Reddick","year":"2004","unstructured":"Hoad-Reddick DA, Evans CR, Norman P, Stockley I. Is there a role for extended antibiotic therapy in a two-stage revision of the infected knee arthroplasty? J Bone Joint Surg Br. 2004;87-B:171\u20134.","journal-title":"J Bone Joint Surg Br"},{"key":"3832_CR35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00003086-199310000-00003","volume":"295","author":"JD Blaha","year":"1993","unstructured":"Blaha JD, Calhoun JH, Nelson CL, Henry SL, Seligson D, Esterhai JL, et al. Comparison of the clinical efficacy and tolerance of gentamicin PMMA beads on surgical wire versus combined and systemic therapy for osteomyelitis. Clin Orthop Relat Res. 1993;295:8\u201312.","journal-title":"Clin Orthop Relat Res"},{"key":"3832_CR36","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00003086-199310000-00014","volume":"295","author":"CL Nelson","year":"1993","unstructured":"Nelson CL, Evans RP, Blaha JD, Calhoun J, Henry SL, Patzakis MJ. A comparison of gentamicin-impregnated polymethylmethacrylate bead implantation to conventional parenteral antibiotic therapy in infected total hip and knee arthroplasty. Clin Orthop Related Res. 1993;295:96\u2013101.","journal-title":"Clin Orthop Related Res"},{"key":"3832_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/01.TA.0000114065.25023.85","volume":"58","author":"HN Shih","year":"2005","unstructured":"Shih HN, Shih LY, Wong YC. Diagnosis and treatment of subacute osteomyelitis. J Trauma. 2005;58:83\u20137.","journal-title":"J Trauma"},{"key":"3832_CR38","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.injury.2017.08.040","volume":"49","author":"WJ Metsemakers","year":"2018","unstructured":"Metsemakers WJ, Morgenstern M, McNally MA, Moriarty TF, McFadyen I, Scarborough M, et al. Fracture-related infection: a consensus on definition from an international expert group. Injury. 2018;49:505\u201310.","journal-title":"Injury."},{"key":"3832_CR39","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/bjc.2011.552","volume":"106","author":"MT King","year":"2012","unstructured":"King MT, Viney R, Smith DP, Hossain I, Street D, Savage E, et al. Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer. Br J Cancer. 2012;106:638\u201345.","journal-title":"Br J Cancer"},{"issue":"9971","key":"3832_CR40","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0140-6736(14)61233-2","volume":"385","author":"L Bernard","year":"2015","unstructured":"Bernard L, Dinh A, Ghout I, Simo D, Zeller V, Issartel B, et al. Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial. Lancet. 2015;385(9971):875\u201382.","journal-title":"Lancet."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3832-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-019-3832-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3832-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T20:49:33Z","timestamp":1665175773000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-019-3832-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3832"],"URL":"https:\/\/doi.org\/10.1186\/s13063-019-3832-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.13884\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.13884\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"29 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study is being conducted in full compliance with the principles of the Declaration of Helsinki and International Conference on Harmonisation Guidelines for Good Clinical Practice. Central ethical approval has been confirmed from the South Central-Oxford C Research Ethics Committee (ref approval no. 18\/SC\/0624) and recruitment will not be initiated at other centres until local ethical approval has been obtained.Informed consent to participate in this study will be obtained from all study participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. No patient-identifiable material will be published.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"693"}}